Wang et al. demonstrated that peripheral amylin treatment reduced levels of the inflammatory markers CD68 and Iba1—two markers directly correlated with the levels of neurofibrillary tangles in AD's models—via amylin's effect on CD68 in microglial cells (Wang E. et al., 2017). This evidence concerns the gene CD68 and Alzheimer disease.